Sort
15,273 grants matching “antimicrobial resistance”
Bacterial Quorum Sensing as Target for Anti-Infective Immunotherapy
$465,302Gunnar Joerg Floris Kaufmann · Scripps Research Institute, The · R01 · FY2011 · AI
Bacterial Quorum Sensing as Target for Anti-Infective Immunotherapy
$465,302Bin Zhou · Scripps Research Institute, The · R01 · FY2012 · AI
Determinants of colonization for commensal skin bacteria
$465,291Tami D Lieberman · Massachusetts Institute Of Technology · R01 · FY2025 · AR
Chemical-based Nitric Oxide Gas-generating Drug Device for the Treatment of Pulmonary Hypertension
$465,219Nagababu Enika · Technology Commercialization Partners, Llc · R41 · FY2020 · HL
Multi-scale modeling and phylodynamics for healthcare associated infections
$465,000Cristina Lanzas · North Carolina State University Raleigh · U01 · FY2023 · CK
Targeting host deubiquitinases for broad spectrum anti-infective therapy
$465,000Mary O'Riordan · University Of Michigan At Ann Arbor · R33 · FY2016 · AI
Targeting host deubiquitinases for broad spectrum anti-infective therapy
$465,000Mary O'Riordan · University Of Michigan At Ann Arbor · R33 · FY2015 · AI
Aneuploidy and Acquired Antifungal Drug Resistance in Candida species
$464,997Anna M. Selmecki · University Of Minnesota · R01 · FY2020 · AI
Novel Electrochemical Bandage for Treatment of Wound Infections
$464,963Robin Patel · Mayo Clinic Rochester · R01 · FY2021 · AI
Mechanisms of DNA glycosylase mediated interstrand crosslink repair
$464,957Brandt F Eichman · Vanderbilt University · R01 · FY2019 · GM
Mechanism of Cif Virulence: A Bacterial Strategy to Subvert Host-Cell Defenses
$464,930Dean R Madden · Dartmouth College · R01 · FY2012 · AI
The Sentinel Event Tracking Network(SETNET)System
$464,898Cereplex · R44 · FY2004 · NR
Mechanistic basis of how LD-transpeptidases protect against outer membrane defects
$464,886Joseph Michael Boll · University Of Texas Arlington · R01 · FY2022 · AI
Novel Electrochemical Bandage for Treatment of Wound Infections
$464,885Robin Patel · Mayo Clinic Rochester · R01 · FY2020 · AI
Mechanistic details of key integral-membrane enzymes for antimicrobial discovery
$464,869William M. Clemons · California Institute Of Technology · R01 · FY2016 · GM
HEALTH MANAGEMENT PROGRAM IS AN ESSENTIAL PART OF MAINTAINING A SUSTAINABLE SMALL RUMINANT OPERATION. THE GREATEST ECONOMIC RETURNS ARE REALIZED WHEN DISEASES CHALLENGES ARE KEPT AT THE LOWEST. HOWEVER, GOAT AND SHEEP PRODUCTION SYSTEMS LACK INFRASTRUCTURE TO COMBAT DISEASE AND ANTIMICROBIAL RESISTANCE (AMR). FEW DRUGS ARE LABELLED FOR GOATS AND SHEEP AND SOME LACK SUFFICIENT EFFICACY TO TREAT PARTICULAR DISEASE CONDITIONS, LEADING TO FREQUENT OFF-LABEL USE. FOR FARMERS TO BE COMPETITIVE IN FOOD ANIMAL COMMERCE, THEY NEED SUPPORT SERVICES ON DISEASES PREVENTION AND ANIMAL HEALTH MANAGEMENT SKILLS. AN OPERATIONAL ANIMAL HEALTH PROGRAM IS AN INDISPENSABLE SHARE OF AN EFFECTIVE GOAT AND SHEEP OPERATION SYSTEMS.THE OVERALL GOAL OF THIS PROJECT IS TO DEVELOP INNOVATIVE SOLUTIONS FOR KEY CHALLENGES IMPACTING GOAT AND SHEEP PRODUCERS.FDA'S PLANS TO BAN OVER-THE-COUNTER ANTIBIOTIC SALES WILL CERTAINLY AFFECT SMALL-SCALE GOAT AND SHEEP PRODUCERS.OFTEN GOAT AND SHEEP PRODUCERS USE ANTIBIOTICS TO MANAGE THE HEALTH OF THEIR ANIMALS WITHOUT MUCH CONSULTATION WITH A VETERINARIAN. MAKING ANTIBIOTICS TO PRESCRIPTION-ONLY, IT DECLARES THE DRUGS WILL BE ADMINISTERED TO ANIMALS UNDER THE SUPERVISION OF A LICENSED VETERINARIAN. THEREFORE, THERE IS A NEED TO ESTABLISH CLIENT-VETERINARY CONNECTION AND TAILOR ANTIMICROBIAL STEWARDSHIP PROGRAMS FOR GOAT AND SHEEP PRODUCERS.IT IS IMPORTANT TO PROVIDE THESE PRODUCERS THE NEEDED TOOLS AND TRAINING ON PRUDENTIAL USE OF ANTIBIOTICS, PREVENTION AND TREATMENT OF ANIMAL DISEASES
$464,816Tennessee State University · · FY2021 · National Institute of Food and Agriculture
Host-mediated zinc sequestration during Acinetobacter baumannii infection
$464,778Eric P Skaar · Vanderbilt University Medical Center · R01 · FY2017 · AI
Human GBPs as regulators of immunity to intracellular bacterial pathogens
$464,767Joern Coers · Duke University · R56 · FY2018 · AI
Efficacy of oral vancomycin prophylaxis for prevention of recurrent C. difficile infection
$464,700Nasia Safdar · University Of Wisconsin-Madison · R01 · FY2021 · HS
Innate immune responses to microbial flora
$464,567Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2012 · AI
Innate immune responses to microbial flora
$464,567Eric G Pamer · Sloan-Kettering Inst Can Research · R01 · FY2011 · AI
Target-based Assays and Screening Strategies for Chemical Probe and Therapeutic Lead Discovery
$464,311James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Impact of bat hibernation on metabolism and immunity to infection
$464,296Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2025 · AI
Enhancing Patient Safety by Preventing Urinary Tract Infection in Post-Acute Care
$464,283Lona Mody · University Of Michigan At Ann Arbor · R01 · FY2021 · HS
Sterilization of Medical Devices with Atmospheric Plasma
$464,103Atmospheric Glow Technologies, Inc. · R44 · FY2004 · GM